Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ABMD - Replacement Heart System -- Ignore unavailable to you. Want to Upgrade?

To: opalapril who wrote (42)	1/31/2001 8:20:15 AM
From: Mark Johnson	Respond to of 147

opal: The FDA approved the AbioCor in record time because of the complete and comprehensive data compiled by Abiomed....I don't think there has been a single mechanical failure in the calf tests. The intial patients who will receive the AbioCor are very sick people who face imminent death. As far as liability concerns.... if the heart has problems the shareholders will feel the markets wrath long before any lawsuits are filed.....but if it works and the AbioCor improves the quality of life in these people with end stage heart failure who knows how high this company will fly.... MJ

To: opalapril who wrote (42)	1/31/2001 5:29:40 PM
From: I. N. Vester	Respond to of 147

opal, might i suggest that you call IR at the company and ask them your questions (or email them)? these are legitimate concerns, but i think the board will be best served not by having investors come here with long lists of questions, but by investors finding answers/info and posting them here. regarding the company's financial resources, they still have almost $100M cash from the secondary offering, and no debt. I consider that information to be extremely basic - it is available in the sec filings, and with due respect, if you have real interest in the company, that should be the first place to start looking for answers. I have partial answers to others of your questions, but it would be much more interesting to hear what the co. tells you concerning cost of trials, etc. etc. I hope you will accept my reply in the positive spirit I'm writing, and that if you do make the effort to get answers you will share them with us. thanks!